Health Ministry to launch anti-bullying guidelines with psychosocial support in October
The guidelines, which apply to all Health Ministry personnel, outline structured measures to prevent, report, and manage bullying incidents across the ministry.
Health Minister Datuk Seri Dr Dzulkefly Ahmad said the guidelines will provide designated reporting channels that ensure confidentiality and protection for complainants.
"As part of the psychosocial support component, victims will be given access to counselling services, referrals to professionals, and also group support," he told the New Straits Times.
He added that confirmed perpetrators would face disciplinary action and undergo counselling interventions.
On mechanisms to ensure compliance, Dzulkefly said heads of departments and management teams would be responsible for cultivating a conducive work environment.
This, he said, includes implementing preventive measures such as awareness campaigns and training sessions to address bullying.
Dzulkefly said monitoring and evaluation would focus on achieving the guidelines' objectives — increasing awareness and reporting, and improving workplace culture and staff well-being.
"It will be carried out through a systematic monitoring mechanism that includes data collection and analysis, as well as assessment of the guidelines' implementation and compliance at Health Ministry facilities," he said.
On July 12, Dzulkefly had said the guideline is a part of broader efforts to strengthen the ministry's support systems, including the "MyHelp KKM" platform.
Currently, bullying cases can be reported through the MyHELP portal, which was launched on Oct 1, 2022.
Reports submitted online must be investigated within 15 working days, depending on whether the case is classified as standard or complex.
Last year, Dzulkefly had also said that the formation of a special task force to look into bullying cases in hospitals.
He had said the task force would investigate bullying cases in general, including those occurring at other healthcare facilities.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
6 hours ago
- The Star
Hepatitis: Infections that drive liver disease
The liver is a vital organ that plays a central role in key bodily functions, including metabolism, immunity, digestion and detoxification. When the liver becomes inflamed or swollen – a condition known as hepatitis – these functions can be disrupted, potentially leading to health complications ranging from mild discomfort to severe liver damage. The most common cause of hepatitis is viral infection. It is classified based on the specific virus involved, i.e. hepatitis A, B, C, D or E. Hepatitis A and E are typically transmitted through contaminated food or water, while hepatitis B, C and D are more commonly spread through contact with infected blood or bodily fluids. Aside from viral infections, other causes of hepatitis include excessive alcohol consumption, exposure to toxins, or certain autoimmune diseases. Several groups face a higher risk of contracting hepatitis, such as healthcare workers, people who use injectable drugs, individuals with multiple sexual partners, and babies born to mothers who are infected with hepatitis. Hepatitis can be classified as either acute or chronic. Acute hepatitis refers to short-term inflammation of the liver, which may resolve on its own without long-term effects. However, in some cases, it can progress into chronic hepatitis. This condition lasts for more than six months and may lead to serious complications, such as cirrhosis, liver failure or liver cancer. In many instances, people with hepatitis do not show any noticeable symptoms during the early stages of infection. As the disease progresses, however, several common symptoms may appear, including: Yellowing of the skin and eyes (jaundice) Dark-coloured urine Fatigue Loss of appetite Nausea Vomiting, or Abdominal pain. In Malaysia Hepatitis infections remain a significant public health challenge in Malaysia. The two most common types are hepatitis B and C, both of which contribute heavily to the national burden of liver-related diseases. Several factors drive the continued spread of these infections, including limited public awareness, restricted access to healthcare in rural areas, and high-risk behaviours. According to Health Ministry statistics, between 2013 and 2023, there were 49,992 reported cases of hepatitis B and 34,573 cases of hepatitis C. In 2016 at the 69th World Health Assembly, Malaysia pledged its commitment to eliminate viral hepatitis as a public health threat by 2030. In line with this goal, the Health Ministry has adopted a multisectoral approach in addressing hepatitis B and C. Collaboration among government agencies, the private sector and non-governmental organisations includes screening efforts, provision of treatment and immunisation services, as well as advocacy and public education initiatives. Public health strategies in the country focus primarily on hepatitis B and C because these types are the main causes of chronic liver disease and liver cancer. In contrast, hepatitis A and E are usually self-limiting and do not require long term treatment, while hepatitis D is rare and only occurs alongside hepatitis B infection. As hepatitis B and C pose a greater burden on the healthcare system, they are prioritised in screening, treatment and prevention efforts. Prevention and treatment One of the key strategies to prevent the spread of hepatitis is immunisation. In Malaysia, vaccines are available for hepatitis A and hepatitis B. Specifically, the hepatitis B vaccine is included in the National Immunisation Programme (NIP) and is routinely administered to newborns. Furthermore, for pregnant mothers who are diagnosed with hepatitis B, antiviral prophylaxis is given to reduce the risk of transmitting the virus to the unborn baby. Apart from immunisation, routine screening for hepatitis is equally important. In particular, it should be prioritised among high risk groups, blood donors and foreign workers. Early detection not only allows for prompt initiation of treatment, but also helps reduce transmission within the community. While prevention remains a crucial aspect in combating hepatitis, effective treatment is equally important in managing the disease. Treatment for viral hepatitis plays a vital role in improving long-term survival. However, not all individuals with hepatitis require treatment. In certain cases, the immune system is capable of limiting the virus from replicating without medical intervention. Therefore, the decision to begin treatment depends on several factors, including liver function, viral load and other co-existing health conditions. For chronic hepatitis B, treatment involves the use of antiviral medications that work by inhibiting viral replication. These include nucleoside analogues such as entecavir, and nucleotide analogues such as tenofovir. These oral medications do not cure hepatitis B, but they help to reduce the risk of serious complications and improve long-term survival. Most patients need to take these medications for life. Another treatment option for hepatitis B is peginterferon alpha injection, which is an immunomodulator that boosts immunity against infection. In Malaysia, this treatment is usually reserved for patients who do not respond to, or cannot tolerate, oral antiviral medications. It is not recommended for pregnant or breastfeeding mothers. On the other hand, hepatitis C is treated with direct-acting antiviral medicines such as sofosbuvir, daclatasvir, ribavirin and ravidasvir. These medications have been shown to cure more than 95% of hepatitis C cases, with shorter treatment duration and fewer side effects. They act by disrupting the virus replication cycle. Before starting this treatment, healthcare providers will explain how to take the medication properly, the importance of not sharing it with others, and the need to avoid any medication that might interact with the treatment. This is to ensure the success of the hepatitis C treatment. Although antiviral medications for hepatitis B and hepatitis C are generally safe and well tolerated, some patients may experience side effects such as headache, nausea, fatigue or skin rashes. If any of these symptoms occur or if there are concerns about starting treatment, it is important to consult a doctor for further advice. Advice for patients In addition to taking prescribed medications, hepatitis patients are advised to maintain a healthy lifestyle. This includes eating a well-balanced diet, engaging in regular physical activity, getting tested for HIV (human immunodeficiency virus), limiting alcohol intake, and getting vaccinated against hepatitis B if they have hepatitis C. Similarly, those with hepatitis B are advised to get tested for hepatitis C. Patients should also consult their healthcare providers before starting any new medications, supplements or traditional products. Moreover, hepatitis patients should avoid behaviours that can lead to transmission of the virus. These include sharing personal items such as toothbrushes, razors or nail clippers, donating blood, and having unprotected sexual intercourse. In conclusion, a better understanding of the many aspects of hepatitis empowers individuals and communities to take proactive steps to prevent infection, seek timely diagnosis and access appropriate treatment. As part of global efforts to raise awareness, World Hepatitis Day is observed annually on July 28. This year's theme 'Let's break it down' underscores the need to overcome barriers in understanding hepatitis so that it can be effectively managed, treated, and ultimately, eliminated. For any inquiries about medicines, please call the National Pharmacy Call Centre (NPCC) at the toll-free number 1-800-88-6722 during weekdays from 8am to 5pm, except on public holidays. Umi Kalthum Mohd Isa is a pharmacist at Hospital Sultan Idris Shah in Serdang, Selangor. This article is courtesy of the Health Ministry's Pharmacy Practice and Development Division. For more information, email starhealth@ The information provided is for educational and communication purposes only, and should not be considered as medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this article. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.
Daily Express
6 hours ago
- Daily Express
Sabah doctor shortage is serious: Warisan
Published on: Monday, July 21, 2025 Published on: Mon, Jul 21, 2025 By: Abbey Junior Text Size: 'There's a silent collapse happening in the system,' Dr Koh (left) said, referring to rising resignation rates, a growing population, and what appears to be insufficient Federal response to staffing needs. Kota Kinabalu: Sabah's healthcare system is crippled by a severe doctor shortage, ageing facilities and geographic isolation. According to Health Ministry data as of April 2025, Sabah – home to 3.742 million – has only one doctor for every 795 people, nearly double the Health Ministry's target ratio of 1:400 and more than three times below the World Health Organization's recommended ratio of 1:225. Of the 9,356 doctors Sabah needs to meet the Health Ministry's minimum ratio, only 4,708 are currently serving in the State. And of these, just 2,522 are permanent medical officers. Advertisement Dr Istefan Koh, health advisor to Parti Warisan and a former doctor, said the data pointed to a worrying trend. 'There's a silent collapse happening in the system,' he said, referring to rising resignation rates, a growing population, and what appears to be insufficient Federal response to staffing needs. He noted that only 28pc of current medical officers in Sabah are local-born, further exacerbating the state's reliance on federal deployments that are often unpredictable or delayed. The turnover rate among medical officers in Sabah was 46pc in 2024, and had already reached 10.3pc by April this year, with most leaving due to contract expiration, transfers, or burnout. Koh said such instability places a heavier burden on the doctors who remain. In one instance, he claimed that a hospital in Semporna saw six out of 21 doctors leave within a month earlier this year. 'Imagine the weight they are carrying,' he said. 'Doctors are saying they want to quit – it's getting very bad in Sabah. What else can we do but wait for reinforcements?' He added that while the population continues to grow, medical staffing has not increased proportionally. In 2023, the ratio stood at 1:680, and it has since worsened. The data also highlights infrastructure constraints. Sabah has 24 hospitals, the majority over 50 years old, many serving remote areas. Distances between facilities can exceed 550km, with some patients travelling up to six hours one way just to access basic care. Nearly half of Sabahans live in rural or island areas, with many living in poverty, making access to specialist care even more difficult. Koh also pointed to facilities like the newly built Hospital Beluran, which remains underutilised due to staffing constraints, and Tawau Hospital, which he said has enough beds but not enough personnel to provide full services. He urged federal health authorities to accelerate promised reforms and provide immediate manpower support, particularly for rural Sabah.
New Straits Times
9 hours ago
- New Straits Times
Guidelines alone won't stop bullying, healthcare groups warn
KUALA LUMPUR: Healthcare groups, in welcoming the Health Ministry's anti-bullying guidelines, stress the need for greater transparency, trust and leadership to drive systemic change. The guidelines, to be launched in October, will include secure and confidential complaint channels and psychosocial support for victims. They also outline clear protocols to prevent, report and manage workplace bullying involving ministry personnel. Malaysian Medical Association (MMA) president Datuk Dr Kalwinder Singh Khaira said the association had long raised concerns over bullying in the sector. He views the ministry's efforts as a step in the right direction. However, he called for broader engagement and public disclosure of the draft guidelines before they were finalised. "MMA's experience in handling bullying complaints can help ensure the measures are effective and practical." He added that MMA maintained a zero-tolerance stance on bullying and that a safe, respectful environment for healthcare workers was essential to ensure high standards of patient care. The Galen Centre for Health and Social Policy said the guidelines' success would depend on the system's credibility and public confidence in how complaints were handled. Its chief executive, Azrul Mohd Khalib, said regular reporting of bullying cases, including outcomes and remedial actions, should be made available — potentially through an online dashboard — to promote accountability and transparency. "This move signals that bullying allegations will be taken seriously and places responsibility on supervisors and Ministry leadership to act." He added that while the provision of confidential channels and psychosocial support was a positive step, the long-term effectiveness of the initiative would depend on how well it is implemented, particularly in overcoming bureaucratic inertia and institutional mistrust. "There must be leadership from the top — from the minister down to state directors and hospital administrators. Training and briefings are key to building confidence in the system. Leaders must lead by example." Hartal Doktor Kontrak lauded the initiative as timely but added that guidelines alone were not enough. Its spokesman, Dr Muhammad Yassin, said enforcement would be the real test. He said that the complaint system's success would depend on its ability to maintain confidentiality. To ensure consistent enforcement in all facilities, Yassin proposed a national-level audit by an independent body to track bullying cases and responses. "Any delays or lack of investigation must be examined to avoid abuse of power," he added. Currently, healthcare workers can report bullying cases through the MyHelp portal, launched in October 2022. Reports must be investigated within 15 working days, depending on whether they are classified as standard or complex.
